| |
|
|
|
| |
|
|
 |
| |
|
|
|
| |
|
|
Composition |
| |
|
|
|
| |
|
|
Each 1 ml of VALOSIN Injection contains:
Valethamate bromide NF XII. . . 8 mg Sodium chloride . . . 8 mg
Water for Injection IP...... Q.s. |
| |
|
|
|
| |
|
|
|
| |
|
|
Therapeutic Indications & Usage |
| |
|
|
|
| |
|
|
VALOSIN is indicated for cervical dilatation in the first stage of labor, as well as in symptomatic relief ofintestinal, ureteric and biliary colics. |
| |
|
|
|
| |
|
|
|
| |
|
|
Contraindications |
| |
|
|
|
| |
|
|
VALOSIN is contraindicated in presence of enlarged prostate, paralytic ileus, pyloric stenosis, ulcerative colitis, toxic megacolon, myasthenia gravis, closed angle glaucoma, hypertension, cardio-vascular disease and hypersensitivity to its ingredients. It is also not to be used during pregnancy.
|
| |
|
|
|
| |
|
|
|
| |
|
|
Precautions & Warnings |
| |
|
|
|
| |
|
|
VALOSIN must be advocated with caution in thyrotoxicosis, cardiac insufficiency, cardiac failure and cardiac surgery wherein the heart rate may further accelerate. |
| |
|
|
Concomitant use of VALOSIN with antihistamines, butyrophenones, phenothiazines and tricyclic antidepressants is to be advocated with caution. The reduction in gastric motility with VALOSIN can affect the absorption of other drugs co-administered. Safety of VALOSIN in children is not known. |
| |
|
|
|
| |
|
|
|
| |
|
|
Adverse Reactions |
| |
|
|
|
| |
|
|
The adverse reactions with valethamate (VALOSIN) include anticholinergic effects such as dryness of mouth, thirst, reduced bronchial secretions, dilatation of pupils with loss of accommodation, flushing and dryness of skin and palpitations. Rarely, there may be hypersensitivity reactions, and central nervous symptoms such as nervousness and giddiness.
|
| |
|
|
|
| |
|
|
|
| |
|
|
Drug interactions |
| |
|
|
|
| |
|
|
The effects of VALOSIN are enhanced when given along with other drugs with antimuscarinic properties such as antihistamines, butyrophenones, phenothiazines and tricyclic anti-depressants is to be advocated with caution. The reduction in gastric motility with VALOSIN can affect the absorption of other drugs co-administered.
|
| |
|
|
|
| |
|
|
|
| |
|
|
Recommended Dosage & Administration |
| |
|
|
|
| |
|
|
ADULTS: 4-8 mg (½-1 ml) VALOSIN deep intramuscular (IM) or slow IV. |
| |
|
|
|
| |
|
|
|
| |
|
|
Presentation |
| |
|
|
|
| |
|
|
VALOSIN Injections: 1 ml ampoules. |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
| |
|
|
|
